Skip to main content
Year archive

GRAFT POLYMER (UK) PLC — 2025 filings

All 63 regulatory filings released by GRAFT POLYMER (UK) PLC (GPL) in 2025, sourced directly from the official regulator.

63 Filings
2025 Period
2025 filings (63)
Filing Released Lang
Research and Development Update – Q4 2025
Regulatory Filings
2025-12-22 English
SVN-015 accepted into US NIDA funded programme
Regulatory Filings
2025-12-03 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements
2025-10-31 English
Corporate Structure Update and Issue of Options
Share Issue/Capital Change
2025-10-31 English
Appoints global biopharma leader Paul Carter
Regulatory Filings
2025-10-27 English
Raises £1.25 Million to Accelerate Programmes
Share Issue/Capital Change
2025-10-16 English
Half-year Report
Interim / Quarterly Report H1 2025
2025-09-30 English
Solvonis secures exclusive CNS collaboration
Regulatory Filings
2025-08-28 English
Media Coverage: Small Cap Idea profile
Regulatory Filings
2025-08-13 English
SVN-SDN-14 PTSD - Positive pre-clinical results
Regulatory Filings
2025-08-12 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements
2025-07-31 English
Translational Bridging Studies
Regulatory Filings
2025-07-22 English
Exercise of warrants
Regulatory Filings
2025-07-18 English
Solvonis Chair to speak at Lucid Capital Markets
Regulatory Filings
2025-07-14 English
£1m subscription to accelerate AI drug discovery
Capital/Financing Update
2025-07-11 English
Holding(s) in Company
Major Shareholding Notification
2025-07-08 English
AGM Statement
AGM Information
2025-06-27 English
Holding(s) in Company
Major Shareholding Notification
2025-06-27 English
Initiation of Research Coverage
Regulatory Filings
2025-06-26 English
Allowance of U.S. patent covering AI-supported CNS
Regulatory Filings
2025-06-23 English
Initiation of AI supported CNS drug discovery
Regulatory Filings
2025-06-11 English
Synthesis of development candidate for SVN-SDN-014
Environmental & Social Information
2025-06-05 English
Proxy form for Annual General Meeting 2025
AGM Information
2025-06-03 English
Notice of Annual General Meeting
AGM Information
2025-06-03 English
Notice of Annual General Meeting
AGM Information
2025-06-03 English
Appointment of Prof. David Nutt as CSO
Regulatory Filings
2025-06-03 English
Holding(s) in Company
Major Shareholding Notification
2025-06-02 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements
2025-05-30 English
Holding(s) in Company
Major Shareholding Notification
2025-05-29 English
Holding(s) in Company
Major Shareholding Notification
2025-05-29 English
Holding(s) in Company
Major Shareholding Notification
2025-05-29 English
Presentation at Mello2025
Regulatory Filings
2025-05-29 English
Holding(s) in Company
Major Shareholding Notification
2025-05-28 English
Completion of the acquisition of Awakn
M&A Activity
2025-05-28 English
Solvonis Therapeutics Plc - Single prospectus
Capital/Financing Update
2025-05-23 English
Publication of a Prospectus
Report Publication Announcement
2025-05-21 English
Result of placing
Regulatory Filings
2025-05-16 English
Proposed equity fundraising via ABB
Capital/Financing Update
2025-05-15 English
Group of companies' accounts made up to 2024-12-31
Regulatory Filings
2025-05-07 English
Annual Financial Report 31 December 2024
Annual Report FY 2024
2025-04-30 English
Signed Resolutions from General Meeting
AGM Information
2025-04-28 English
Result of General Meeting
Regulatory Filings
2025-04-28 English
Proposed acquisition of Awakn approved
M&A Activity
2025-04-23 English
Final Results for the year ended 31 December 2024
Annual Report FY 2024
2025-04-16 English
Proxy Form for General Meeting
Proxy Solicitation & Information Statement
2025-04-14 English
Notice of General Meeting
Proxy Solicitation & Information Statement
2025-04-14 English
Posting of Circular and Notice of General Meeting
Regulatory Filings
2025-04-10 English
Holding(s) in Company
Major Shareholding Notification
2025-04-07 English
Engagement of PharmaVentures
Regulatory Filings
2025-04-04 English
Positive progress on European Patent Application
Regulatory Filings
2025-03-26 English
Update on AWKN-SDN-14 programme
Regulatory Filings
2025-03-18 English
Holding(s) in Company
Major Shareholding Notification
2025-03-11 English
Appointment of Non-Executive Director
Board/Management Information
2025-03-11 English
Presentation at PharmaSynergyRx Event
Regulatory Filings
2025-02-25 English
Entry into an Arrangement Agreement with Awakn
Interim / Quarterly Report 9M 2024
2025-02-24 English
Proactive Investors interview with Chairman
Regulatory Filings
2025-01-30 English
Update on Awakn Life Sciences’ R&D Progress
Regulatory Filings
2025-01-27 English
Investor Presentation
Regulatory Filings
2025-01-24 English
Proactive Investors interview with CEO
Investor Presentation
2025-01-21 English
Update on FDA Pre-IND Meeting for Awakn
Regulatory Filings
2025-01-21 English
Interview with CEO
Regulatory Filings
2025-01-15 English
Change of Name to Solvonis Therapeutics plc
Regulatory Filings
2025-01-14 English
Result of General Meeting and change of name
AGM Information
2025-01-06 English